Maintenance of Efficacy.

This study has been withdrawn prior to enrollment.

( This study has been cancelled as the esreboxetine development program is being discontinued. Safety and efficacy were not factors. )

Study NCT00796601 Information provided by Pfizer

First Received: November 20, 2008 Last Updated: March 17, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	November 2010
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)